Literature DB >> 12628061

Antiepileptic Drugs in Children with Developmental Delays and Behavioral Problems.

John M. Pellock1.   

Abstract

Children with multiple handicaps, including developmental delays and behavioral problems, frequently have epilepsy that requires treatment. Different strategies should be used for acute treatment versus chronic treatment. Experience suggests that there is no true drug of choice that can be used for all children with epilepsy; however, seizure type, epilepsy syndrome, and likely efficacy and side effect spectrum of the antiepileptic drug (AED) will determine the best treatment for each child. In general, phenobarbital has posed multiple behavioral problems, and, thus, is less commonly used. Carbamazepine is the most frequently used drug for the treatment of partial seizures with or without secondary generalization, and valproate is the long established, broad spectrum AED for children with generalized convulsive and nonconvulsive seizures. Newer AEDs allow alternative treatments to those with adverse effects to the more frequently used medications and may have cognitive or behavioral advantages.

Entities:  

Year:  2003        PMID: 12628061     DOI: 10.1007/s11940-003-0003-2

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  4 in total

Review 1.  Patients with refractory seizures.

Authors:  O Devinsky
Journal:  N Engl J Med       Date:  1999-05-20       Impact factor: 91.245

Review 2.  Treatment of epilepsy in the multiply handicapped.

Authors:  J M Pellock; L D Morton
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2000

Review 3.  Managing pediatric epilepsy syndromes with new antiepileptic drugs.

Authors:  J M Pellock
Journal:  Pediatrics       Date:  1999-11       Impact factor: 7.124

4.  A decade of modern epilepsy therapy in institutionalized mentally retarded patients.

Authors:  J M Pellock; P A Hunt
Journal:  Epilepsy Res       Date:  1996-11       Impact factor: 3.045

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.